Phytoestrogen intake and risk of ovarian cancer: A meta-analysis of 10 observational studies

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 21, 2014, Pages 9085-9091

  Qu, Xin Lan ^a   Fang, Yuan ^a   Zhang, Ming ^a   Zhang, Yuan Zhen ^a  

^a ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Isoflavones; Meta analysis; Ovarian cancer; Phytoestrogen; Soy food

Indexed keywords

PHYTOESTROGEN;

CHINA; DIET; FEMALE; HUMAN; INCIDENCE; META ANALYSIS; OBSERVATIONAL STUDY; OVARIAN NEOPLASMS; PROGNOSIS; RISK FACTOR;

CHINA; DIET; FEMALE; HUMANS; INCIDENCE; OBSERVATIONAL STUDY AS TOPIC; OVARIAN NEOPLASMS; PHYTOESTROGENS; PROGNOSIS; RISK FACTORS;

EID: 84918558608     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.21.9085     Document Type: Article

References (49)

1. Allred CD, Allred KF, Ju YH, Virant SM, Helferich WG (2001). Soy diets containing varying amounts of genistein stimulate growth of estrogen-dependent (MCF-7) tumors in a dosedependent manner. Cancer Res, 61, 5045-50.
2. Andres S, Appel KAK (2011). Risks and benefits of dietary isoflavones for cancer. Crit Rev Toxicol, 41, 463-506.
3. Bandera EV, King M, Chandran U, et al (2011). Phytoestrogen consumption from foods and supplements and epithelial ovarian cancer risk: a population-based case control study. BMC Womens Health, 11, 40.
4. Banerjee S, Li Y, Wang Z, Sarkar FH (2008). Multi-targeted therapy of cancer by genistein. Cancer Lett, 269, 226-42.
5. Begg CB, Mazumdar M (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics, 50, 1088-101.
6. Chang ET, Lee VS, Canchola AJ, et al (2007). Diet and risk of ovarian cancer in the California Teachers Study cohort. Am J Epidemiol, 165, 802-13.
7. Chen X, Anderson JJ (2001). Isoflavones inhibit proliferation of ovarian cancer cells in vitro via an estrogen receptordependent pathway. Nutr Cancer, 41, 165-71.
8. Choi EJ, Kim T, Lee MS (2007). Pro-apoptotic effect and cytotoxicity of genistein and genistin in human ovarian cancer SK-OV-3 cells. Life Sci, 80, 1403-8.
9. DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88.
10. Dong JY, Zhang YH, Qin LQ (2011). Erectile dysfunction and risk of cardiovascular disease: meta-analysis of prospective cohort studies. J Am Coll Cardiol, 58, 1378-85.
11. Dorward AM, Shultz KL, Beamer WG (2007). LH analog and dietary isoflavones support ovarian granulosa cell tumor development in a spontaneous mouse model. Endocr Relat Cancer, 14, 369-79.
12. Egger M, Davey SG, Schneider M, Minder C (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34.
13. Gates MA, Tworoger SS, Hecht JL, et al (2007). A prospective study of dietary flavonoid intake and incidence of epithelial ovarian cancer. Int J Cancer, 121, 2225-32.
14. Gates MA, Vitonis AF, Tworoger SS, et al (2009). Flavonoid intake and ovarian cancer risk in a population-based casecontrol study. Int J Cancer, 124, 1918-25.
15. Gercel-Taylor C, Feitelson AK, Taylor DD (2004). Inhibitory effect of genistein and daidzein on ovarian cancer cell growth. Anticancer Res, 24, 795-800.
16. Gossner G, Choi M, Tan L, et al (2007). Genistein-induced apoptosis and autophagocytosis in ovarian cancer cells. Gynecol Oncol, 105, 23-30.
17. Green JM, Alvero AB, Kohen F, Mor G (2009). 7-(O)-Carboxymethyl daidzein conjugated to N-t-Bochexylenediamine: a novel compound capable of inducing cell death in epithelial ovarian cancer stem cells. Cancer Biol Ther, 8, 1747-53.
18. Hall JM, Couse JF, Korach KS (2001). The multifaceted mechanisms of estradiol and estrogen receptor signaling. J Biol Chem, 276, 36869-72.
19. Hedelin M, Lof M, Andersson TM, Adlercreutz H, Weiderpass E (2011). Dietary phytoestrogens and the risk of ovarian cancer in the women's lifestyle and health cohort study. Cancer Epidemiol Biomarkers Prev, 20, 308-17.
20. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003). Measuring inconsistency in meta-analyses. BMJ, 327, 557-60.
21. Jefferson WN, Couse JF, Padilla-Banks E, Korach KS, Newbold RR (2002). Neonatal exposure to genistein induces estrogen receptor (ER)alpha expression and multioocyte follicles in the maturing mouse ovary: evidence for ERbeta-mediated and nonestrogenic actions. Biol Reprod, 67, 1285-96.
22. Jefferson WN, Patisaul HB, Williams CJ (2012). Reproductive consequences of developmental phytoestrogen exposure. Reproduction, 143, 247-60.
23. Kang HB, Zhang YF, Yang JD, Lu KL (2012). Study on soy isoflavone consumption and risk of breast cancer and survival. Asian Pac J Cancer Prev, 13, 995-8.
24. Kim SH, Park MJ (2012). Effects of phytoestrogen on sexual development. Korean J Pediatr, 55, 265-71.
25. Lee AH, Su D, Pasalich M, Tang L, Binns CW, Qiu L (2014). Soy and isoflavone intake associated with reduced risk of ovarian cancer in southern Chinese women. Nutr Res, 34, 302-7.
26. Leung PC, Choi JH (2007). Endocrine signaling in ovarian surface epithelium and cancer. Hum Reprod Update, 13, 143-62.
27. Luo H, Jiang BH, King SM, Chen YC (2008). Inhibition of cell growth and VEGF expression in ovarian cancer cells by flavonoids. Nutr Cancer, 60, 800-9.
28. Manzoli L, Villari P, M PG, Boccia A (2007). Marital status and mortality in the elderly: a systematic review and metaanalysis. Soc Sci Med, 64, 77-94.
29. McCann SE, Freudenheim JL, Marshall JR, Graham S (2003). Risk of human ovarian cancer is related to dietary intake of selected nutrients, phytochemicals and food groups. J Nutr, 133, 1937-42.
30. Ning Y, Li Q, Xiang H, Liu F, Cao J (2012). Apoptosis induced by 7-difluoromethoxyl-5,4'-di-n-octyl genistein via the inactivation of FoxM1 in ovarian cancer cells. Oncol Rep, 27, 1857-64.
31. Ososki AL, Kennelly EJ (2003). Phytoestrogens: a review of the present state of research. Phytother Res, 17, 845-69.
32. Rossi M, Bosetti C, Negri E, Lagiou P, La Vecchia C (2010). Flavonoids, proanthocyanidins, and cancer risk: a network of case-control studies from Italy. Nutr Cancer, 62, 871-7.
33. Rossi M, Negri E, Lagiou P, et al (2008). Flavonoids and ovarian cancer risk: A case-control study in Italy. Int J Cancer, 123, 895-8.
34. Rucinska A, Kirko S, Gabryelak T (2007). Effect of the phytoestrogen, genistein-8-C-glucoside, on Chinese hamster ovary cells in vitro. Cell Biol Int, 31, 1371-8.
35. Sakauchi F, Khan MM, Mori M, et al (2007). Dietary habits and risk of ovarian cancer death in a large-scale cohort study (JACC study) in Japan. Nutr Cancer, 57, 138-45.
36. Solomon LA, Ali S, Banerjee S (2008). Sensitization of ovarian cancer cells to cisplatin by genistein: the role of NF-kappaB. J Ovarian Res, 1, 9.
37. Srisuttayasathien M, Khemapech N (2013). Quality of life in ovarian cancer patients choosing to receive salvage chemotherapy or palliative treatment. Asian Pac J Cancer Prev, 14, 7669-74.
38. Sugiyama Y, Masumori N, Fukuta F, et al (2013). Influence of isoflavone intake and equol-producing intestinal flora on prostate cancer risk. Asian Pac J Cancer Prev, 14, 1-4.
39. Tamaya T (2005). Phytoestrogens and reproductive biology. Reprod Med Biol, 4, 225-9.
40. Tanaka T, Kohno H, Tanino M, Yanaida Y (2002). Inhibitory effects of estrogenic compounds, 4-nonylphenol and genistein, on 7,12-dimethylbenz[a]anthracene-induced ovarian carcinogenesis in rats. Ecotoxicol Environ Saf, 52, 38-45.
41. Thasni KA, Rojini G, Rakesh SN, et al (2008). Genistein induces apoptosis in ovarian cancer cells via different molecular pathways depending on breast cancer susceptibility gene-1 (BRCA1) status. Eur J Pharmacol, 588, 158-64.
42. Wang L, Lee IM, Zhang SM, (2009). Dietary intake of selected flavonols, flavones, and flavonoid-rich foods and risk of cancer in middle-aged and older women. Am J Clin Nutr, 89, 905-12.
43. Wells G, Shea B, O Connell D, Peterson J, Welch V, Losos M, et al. The newcastle -scale(NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available from:http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp (cited 19 March 2011).
44. Woclawek-Potocka I, Mannelli C, Boruszewska D, Kowalczyk-Zieba I, Wasniewski T, Skarzynski DJ (2013). Diverse effects of phytoestrogens on the reproductive performance: cow as a model. Int J Endocrinol, 2013, 650984.
45. WOOLF B (1955). On estimating the relation between blood group and disease. Ann Hum Genet, 19, 251-3.
46. Yang WS, Va P, Wong MY, Zhang HL, Xiang YB (2011). Soy intake is associated with lower lung cancer risk: results from a meta-analysis of epidemiologic studies. Am J Clin Nutr, 94, 1575-83.
47. Zhang M, Xie X, Lee AH, Binns CW (2004). Soy and isoflavone intake are associated with reduced risk of ovarian cancer in southeast china. Nutr Cancer, 49, 125-30.
48. Zhang YF, Kang HB, Li BL, Zhang RM (2012). Positive effects of soy isoflavone food on survival of breast cancer patients in China. Asian Pac J Cancer Prev, 13, 479-82.
49. Zhao E, Mu Q (2011). Phytoestrogen biological actions on mammalian reproductive system and cancer growth. Sci Pharm, 79, 1-20.